» Articles » PMID: 39609864

SS31 Alleviates LPS-induced Acute Lung Injury by Inhibiting Inflammatory Responses Through the S100A8/NLRP3/GSDMD Signaling Pathway

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2024 Nov 28
PMID 39609864
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is an acute, diffuse, inflammatory lung injury caused by various endogenous or exogenous factors. It is currently widely recognized that an excessive inflammatory response resulting from immune imbalance constitutes a crucial pathogenic mechanism in ALI/ARDS. SS31 is a novel mitochondria-targeted antioxidant peptide. This article validates the role of SS31 in lipopolysaccharide (LPS)-induced ALI.

Methods: The study applied transcriptome sequencing, immunofluorescence, PCR, immunofluorescence and other methods to explore the mechanism of SS31 in LPS induced ALI.

Results: Transcriptome sequencing results indicate that LPS-induced ALI is closely associated with immune regulatory processes, the Toll-like receptor pathway, and the NF-κB signaling pathway. The role of SS31 in acute lung injury is closely related to biological processes, such as immune regulation and cell death. This study demonstrated that SS31 can inhibit the expression of inflammatory factors IL-6, IL-1β, IL-18, and TNF-α, and reduce the expression of pyroptosis-related proteins NLRP3, and GSDMD-N. Further analysis revealed that S100A8 may be a key gene in the effect of SS31. LPS stimulation leads to increased expression of S100A8, while SS31 decreases its expression. Recombinant protein S100A8 can attenuate the inhibitory effect of SS31 on IL-1β, IL-18, NLRP3, and GSDMD-N.

Conclusions: The research results indicate that SS31 may inhibit the activation of the NLRP3 inflammasome and suppress inflammatory responses by regulating S100A8, thereby alleviating LPS-induced ALI in mice; this process may be related to pyroptosis.

References
1.
Fei L, Jingyuan X, Fangte L, Huijun D, Liu Y, Ren J . Preconditioning with rHMGB1 ameliorates lung ischemia-reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway. J Transl Med. 2020; 18(1):301. PMC: 7405465. DOI: 10.1186/s12967-020-02467-w. View

2.
Anwar M, Shah M, Kim J, Choi S . Recent clinical trends in Toll-like receptor targeting therapeutics. Med Res Rev. 2018; 39(3):1053-1090. PMC: 6587958. DOI: 10.1002/med.21553. View

3.
Kong X, Gao M, Liu Y, Zhang P, Li M, Ma P . GSDMD-miR-223-NLRP3 axis involved in B(a)P-induced inflammatory injury of alveolar epithelial cells. Ecotoxicol Environ Saf. 2022; 232:113286. DOI: 10.1016/j.ecoenv.2022.113286. View

4.
Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View

5.
Suo M, Qi Y, Liu L, Zhang C, Li J, Yan X . SS31 Alleviates Pressure Overload-Induced Heart Failure Caused by Sirt3-Mediated Mitochondrial Fusion. Front Cardiovasc Med. 2022; 9:858594. PMC: 9110818. DOI: 10.3389/fcvm.2022.858594. View